Research shows that they can interfere with multiple signaling pathways in cancer cells, like NF-κB and STAT3 (which promote inflammation and cell survival), PI3K/Akt (involved in cell growth), and processes that lead to tumor invasion (like the epithelial–mesenchymal transition). This evidence concerns the gene AKT1 and cancer.